$$ Banyan Corporation - nächster Pennykracher ? $$

Beiträge: 13
Zugriffe: 1.093 / Heute: 4
BANYAN CORP . kein aktueller Kurs verfügbar
 
Plutoman:

$$ Banyan Corporation - nächster Pennykracher ? $$

 
08.03.07 09:24
US-Kürzel: BANY
WKN: 909155
Handelbar an der OTC

Market Cap: 677.99K
Kurs aktuell bei 0,0014$

Ich sehe bei BANY großes Potential, freue mich auf eine rege Diskussion und werde hier einiges über Banyan Corporation zusammentragen.  

Werbung

Entdecke die beliebtesten ETFs von Amundi

Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi ETF Leveraged MSCI USA Daily UCITS ETF - EUR (C/D)
Perf. 12M: +72,57%
Amundi Nasdaq-100 Daily (2x) Leveraged UCITS ETF - Acc
Perf. 12M: +65,82%
Amundi Russell 1000 Growth UCITS ETF - Acc
Perf. 12M: +38,69%
Amundi MSCI Wld Clim. Paris Align. PAB Umw. UCITS ETF DR C/D
Perf. 12M: +37,70%

Plutoman:

Letzte News

 
08.03.07 09:26
Banyan Corporation Reports Strong Sales For Its Virtual Medical Systems, Inc. Subsidiary
Thursday January 11, 11:15 am ET

LOS ANGELES--(BUSINESS WIRE)--Banyan Corporation's (OTCBB:BANY - News) subsidiary, Virtual Medical Systems, Inc. ("VMS"), announces it has now sold 66 of its new VT3000 Nerve Conduction Velocity (NCV) testing devices since November 2006. The VT3000 is a state of the art NCV device offering live viewing and supervision of testing by board certified physicians. These 66 machines are expected to add $1.58 million in revenue to VMS. The company, in an earlier release, reported that management projected 2007 sales of 144 machines corresponding to $3.4 million in revenue. Now, as a result of these increased sales, management has revised its estimates upward to 166 machines and $3.98 million in revenue.

Banyan CEO Michael Gelmon stated, "This is exciting news, but not unexpected. The diagnostic industry has long been waiting for the development of a machine with the properties of the VT3000. In December, 36% of the patients tested in our diagnostic testing subsidiary were being tested utilizing proprietary technology incorporated in the VT3000. We believe our technology should be the gold standard in the industry shortly. In addition, it represents significant growth and long term viability of the VMS model."

For more information on Chiropractic USA, Diagnostic USA, and Premier Medical Group contact Banyan Corporation, Investor Relations, toll-free at (800) 808-0899 or visit www.chiropracticUSA.net.

About Banyan Corporation

Banyan Corporation is a publicly traded holding company focused on investing in and building a network of operating subsidiaries engaged in various innovative businesses. Currently the company's subsidiary, Chiropractic USA, Inc. is focusing on the development of branded chiropractic clinics throughout North America by way of franchising chiropractic clinics under its marks and uniform operating systems and practices. The company's other subsidiaries; Premier Medical Group LLC, and Diagnostic USA, Inc. provide diagnostic testing to physicians nationwide.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Banyan Corporation) contains statements that are forward-looking, such as statements relating to the future anticipated direction of the high technology industry, plans for future expansion, various business development activities, planned capital expenditures, future funding sources, anticipated sales growth and potential contracts. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of Banyan Corporation. These risks and uncertainties include, but are not limited to, those relating to development and expansion activities, dependence on existing management, financing activities, domestic and global economic conditions, changes in federal or state tax laws, and market competition factors. For a description of additional risks and uncertainties, please refer to Banyan's filings with the Securities and Exchange Commission.

Contact:
Banyan Corporation, Los Angeles
Michael Gelmon, CEO, 800-808-0899
adavis@chiropracticusa.net
www.ChiropracticUSA.net

--------------------------------------------------
Source: Banyan Corporation
Plutoman:

Chart

 
08.03.07 09:33
Die News vom 11.01.2007 hat den Kurs auf fast 0,005$ hochkatapultiert.  
(Verkleinert auf 65%) vergrößern
$$ Banyan Corporation - nächster Pennykracher ? $$ 86434
Plutoman:

Kursziel 0,01$

 
08.03.07 11:05
The company reports initial sales of 50 machines, with sales of 50 additional machines expected within the next 90 days. Between the machine sales and ongoing testing revenues, these sales alone should generate yearly revenues of about $3,000,000- $4,000,000 from this initial marketing effort. This is in addition to the existing Premier business that is reporting strong growth for the quarter ending September 30, 2006.

Michael Gelmon, Banyan CEO, speaking to analysts said, "I am very excited about the rapid growth of our VT3000 and the revenue potential that will add substantially to Banyan\\'s bottom line. Revenue from our Diagnostic business as reported in our recent 10Q filings have exceeded $5.4 million on an annualized basis, this additional income will help us turn the corner to profitability. Within 5 years, the market for the VT3000 could exceed 2,000 units per year and produce a yearly revenue in excess of $40,000,000."
Plutoman:

BANY bald sogar bei 0,07$ ?

 
08.03.07 11:16
Posted by: t777
In reply to: None Date:2/26/2007 8:07:11 PM
Post #of 7589

From Yahoo- Fundamental price value for BANY (2 Ratings) 25-Feb-07 08:06 pm Here is a little sensitivity analysis using the earnings per share * price to earnings ratio to get the price of BANY that I came up with.

note* there are a lot of "what if's" to take into account concerning:
1 number of shares outstanding
2 if bany can reach a level of positive earnings per share
3 and if they can reach positive eps, what will it be
4 how much will expenses be this quarter

Once the next report comes out, we will know a lot more about these crucial "what if's" and can get a good sense of what the stock is worth.

Here is my analysis:
In looking at the quarterly income statements (through yahoo), for the period ending sept 30, 06: bany had revenues of $1.432 and a negative net income of -$576,000. Since then, there was a press release saying 66 VT3000 machines were sold adding revenues of 1.58 million since nov 2006. This was announced on Jan. 11th. how much of that revenue can be counted in the next quarter (oct, nov, dec)? I would say almost all of it since it was announced just after the end of december, but we will only add 2/2.333*1.58=1.3545million. The 2 comes from the two months in the quarter that the new revenue should have been colected and the 2.333 is the total time of selling the 66 machines. So to sum up, 85.73% of the revenue from selling the 66 machines since november should have been collected in this last quarter. Now our revenues for oct, nov, and dec are around the 1.3545 million(selling the vt3000) plus the last quarter revenues of 1.432 million equals 2.7865 million. This does not include any revenue growth from franchising new clinics during that quarter. I don't have the best idea in finding out how much new revenue was gained just from the new franchises, but the growth in revenue from the previous quarter (june 30th) to sep 30th (which is before vt3000 machine sales) is 6.79%. If you take the ending revenue - the beginning revenue divided by the beginning revenue, you get .0679 or 6.79%. I am assuming at the minimum the revenue grew 6.79% in the quarter. You could also find the arithmatic mean in revenue growth from the last three quarters starting at the quarter ending december 31 05. That is 164.367% average revenue growth over the last three quarters. 1.0679*1432 = 1.529 million in revenue at the minimum just for the franchising revenue. So a low end revenue estimate for the 4th quarter of 06 (1.529 m + 1.3545 m) is 2.8835 million. If we assume the same exp, which is not very good, but it is all i really have, net income for the quarter will be around $875,000 dollars. Multiply that by 4 and you get $3,500,000 in net income for next year. If you divide that by the number of shares outstanding, which no one knows so we we will say 1 billion, you get .0035 earnings per share or eps. So .0035 eps is a low end times a higher multiple for the growth rate we are seeing, andywhere from 20 to 40, you get a price per share of .07 or 7 cents per share to 14 cents per share. This does not include what would happen to the price considering all short coverings. So just something for everyone to consider when looking at BANY. 7 to 14 cents per share!!!!!

my opinion only

Sentiment : Strong Buy
You have rated  
Plutoman:

mal schauen ....

 
08.03.07 13:40
was USA heute macht
Plutoman:

BANY inzwischen wohl profitabel

 
08.03.07 13:58
Demnächst kommt der Jahresbericht 2006 und so wie ich die Berechnung in Posting 5 verstehe, wird BANY erstmals einen Profit ausweisen.

Das wird den Kurs nach oben treiben.  
Plutoman:

werde in den nächsten Tagen

 
08.03.07 14:18
weiter aufstocken
Plutoman:

wird Zeit für den Turnaround o. T.

 
08.03.07 14:54
Plutoman:

News sind überfällig

 
08.03.07 15:12
und die nächsten werden mit Sicherheit wieder sehr gut ausfallen
Plutoman:

$$$ +54,55 % $$$ o. T.

 
22.03.07 08:47
Plutoman:

Hier die News

 
22.03.07 08:53
Banyan Subsidiary, Premier Medical Group Announces 4th Acquisition
Mar 21, 2007 12:01:00 PM

Copyright Business Wire 2007
LOS ANGELES--(BUSINESS WIRE)--

Banyan Corporation (OTCBB:BANY), franchisors of nationally branded Chiropractic USA clinics, and owner of Premier Medical Group and Virtual Medical Systems, Inc. (VMS), announced the Acquisition of the customer base of Medical Resources, Inc. of Virginia. Premier Medical Group is now considered to be one of the largest electro diagnostic testing companies in the USA.

Michael Gelmon, Banyan CEO, speaking to analysts said that this acquisition would add initially about $1.3 million in annual revenue to Premier based on the number and size of accounts acquired, as well as add substantial revenue to VMS. VMS sells the highly recognized VT3000 nerve testing device to medical and chiropractic practices across the United States. "Acquiring revenue streams throughout our operating businesses is a sound approach to bring about rapid growth for Banyan," said Michael Gelmon. "While this is our 4th acquisition for Premier, the potential for continued acquisitions is great as we seek to consolidate the electro diagnostic industry".

"Revenues from Banyan\'s core businesses are expected to grow to an estimated $7.4 million on an annualized basis, turning the corner to profitability," said Gelmon.

Banyan agreed to pay Medical Resources 30% of the gross collections from its former accounts until the purchase price of $440,000 has been paid in full.

About Banyan Corporation:

Banyan Corporation is a publicly traded holding company focused on investing in and building a network of operating subsidiaries engaged in various innovative businesses. Currently the company\'s subsidiary, Chiropractic USA, Inc. is focusing on the development of branded Chiropractic clinics throughout North America by way of franchising and the use of uniform operating systems and practices. The company\'s other subsidiaries, Premier Medical Group LLC, and Virtual Medical Systems, Inc., provide diagnostic testing services to physicians nationwide in addition to marketing the VT3000 Electro-diagnostic testing machine.

This Press Release contains or incorporates by reference forward looking statements including certain information with respect to plans and strategies of Banyan Corporation. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Banyan Corporation operations that could differ materially from those indicated by such forward looking statements.

Source: Banyan Corporation

----------------------------------------------
Banyan Corporation
Los Angeles
Investor Relations
Michael Gelmon
1-800-808-0899
www.ChiropracticUSA.net  
Plutoman:

BANY ist gelaufen, als nächstes ist QMMG dran ! o. T.

 
22.03.07 09:09
Es gibt keine neuen Beiträge.


Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem BANYAN CORP (ORE) Forum

Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
  12 $$ Banyan Corporation - nächster Pennykracher ? $$ Plutoman Plutoman 22.03.07 09:09
2 13 +400 % karibik RoulettProfi 05.12.06 20:31

--button_text--